Title

A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2

UMMS Affiliation

Department of Medicine, Division of Cardiovascular Medicine; Department of Pediatrics, Division of Pediatric Cardiology

Publication Date

2021-09-01

Document Type

Response or Comment

Disciplines

Cardiology | Cardiovascular Diseases | Immunology and Infectious Disease | Infectious Disease | Virus Diseases

Abstract

Wide availability of the 3 vaccines approved by the U.S. Food and Drug Administration for emergency use against SARS-CoV-2 has led to reports of adverse reactions not seen during clinical trials: We now report a series of patients who developed CMR-proven myocarditis shortly after vaccination.

Keywords

SARS-CoV-2, COVID-19, vaccines, myocarditis

DOI of Published Version

10.1016/j.jcmg.2021.06.003

Source

Dickey JB, Albert E, Badr M, Laraja KM, Sena LM, Gerson DS, Saucedo JE, Qureshi W, Aurigemma GP. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021 Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID: 34246585; PMCID: PMC8219373. Link to article on publisher's site

Journal/Book/Conference Title

JACC. Cardiovascular imaging

Related Resources

Link to Article in PubMed

PubMed ID

34246585

Share

COinS